Correlation Between Virpax Pharmaceuticals and Catalyst Biosciences

Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and Catalyst Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and Catalyst Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virpax Pharmaceuticals and Catalyst Biosciences, you can compare the effects of market volatilities on Virpax Pharmaceuticals and Catalyst Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of Catalyst Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and Catalyst Biosciences.

Diversification Opportunities for Virpax Pharmaceuticals and Catalyst Biosciences

-0.69

Correlation Coefficient

Virpax Pharmaceuticals  Catalyst Biosciences

Excellent diversification

The 3 months correlation between Virpax and Catalyst is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and Catalyst Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Biosciences and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with Catalyst Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Biosciences has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and Catalyst Biosciences go up and down completely randomly.

Pair Corralation between Virpax Pharmaceuticals and Catalyst Biosciences

If you would invest  41.00  in Catalyst Biosciences on September 15, 2024 and sell it today you would earn a total of  0.00  from holding Catalyst Biosciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	0.37%
Values	Daily Returns

Virpax Pharmaceuticals  vs.  Catalyst Biosciences

Virpax Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Virpax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Catalyst Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Catalyst Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Catalyst Biosciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Virpax Pharmaceuticals and Catalyst Biosciences

The main advantage of trading using opposite Virpax Pharmaceuticals and Catalyst Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, Catalyst Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Biosciences will offset losses from the drop in Catalyst Biosciences' long position.

The idea behind Virpax Pharmaceuticals and Catalyst Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.